Sertraline and Reviparin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordReviparin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You're taking sertraline (an antidepressant) along with reviparin (a blood-thinner injection). Both can make bleeding more likely, and using them together adds those effects up. Sertraline lowers the amount of serotonin your platelets use to help form clots, and reviparin already slows clotting on its own.
This doesn't mean something bad will happen, but it's worth watching for. Look out for things like nosebleeds, easy bruising, or bleeding that won't stop. The good news is your care team can manage this well by keeping a closer eye on you. Please don't stop either medicine on your own, just talk with your doctor or pharmacist about it.
Effect: Additive bleeding risk with concurrent sertraline and reviparin (a low molecular weight heparin).
Mechanism: SSRIs inhibit platelet serotonin reuptake, depleting platelet serotonin needed for hemostasis; this compounds reviparin's anticoagulant (antithrombin-mediated anti-Xa) effect. This is a pharmacodynamic interaction, not CYP-mediated.
- Direction: Increased bleeding risk (additive)
- Onset: Delayed
- Evidence: Probable (case-control and cohort data)
- Severity: Major
Management: Monitor for bleeding (epistaxis, ecchymosis, hematoma, petechiae, GI/major hemorrhage). Counsel the patient on bleeding signs. Anticoagulation may need individualized adjustment by the care team; escalate for significant bleeding.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is administered together with an anticoagulant, watch the patient for indications of heightened bleeding and warn patients regarding the elevated bleeding risk.1. Platelet-driven serotonin release plays a key role in preserving hemostasis. An increased bleeding risk has been linked to the joint use of SSRIs (sertraline among them) and anticoagulants in both case-control and cohort investigations 231. Taking sertraline alongside an anticoagulant can heighten the likelihood of bleeding. Among the bleeding events that have been documented are epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
Both medicines raise bleeding risk, so the main approach is watchful monitoring, not stopping treatment.
- Keep taking both exactly as prescribed unless your prescriber tells you otherwise.
- Your care team may monitor you more closely and individualize your blood-thinner plan.
- Watch for warning signs: frequent nosebleeds, easy bruising, tiny red skin spots, blood in urine or stool, black stools, or bleeding that won't stop.
- Seek urgent care for heavy or uncontrolled bleeding.
Bring up any bruising or bleeding with your pharmacist or doctor so they can tailor your care.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) reported a heightened risk of clinically relevant bleeding (hospitalization due to bleeding) among patients taking warfarin for atrial fibrillation while also receiving SSRI therapy or within 2 weeks after stopping SSRI therapy. Patients with a mean age of 72 +/- 7 years who received warfarin plus SSRI (n=117) were matched to randomly chosen patients who received warfarin alone (n=117). The SSRIs included FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, nine patients had 11 bleeding episodes over 213.9 treatment years, whereas in the warfarin-only group, 10 patients had 14 bleeds over 586.4 treatment years. The corresponding total bleeding incidences were 51.4 and 23.9 per 1000 treatment years, respectively. The hazard ratio for first bleedings during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009) relative to warfarin alone. The SSRIs involved in patients who bled during concomitant use were sertraline or citalopram. Adding an SSRI was not linked to a change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The study's findings may be constrained by prior bleeding events, unknown patient adherence, and the exclusion from the model of clopidogrel, dipyridamol, corticosteroids and anticoagulants other than warfarin 2.
b) A population-based, case-controlled study of new coumarin users (acenocoumarol and phenprocoumon) taking concurrent selective serotonin reuptake inhibitors (SSRIs) found an elevated risk of hospitalization for non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, researchers identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also on a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients using SSRIs had greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) was not significantly different 3.
c) A non-blinded, randomized, placebo-controlled trial with 12 healthy volunteers evaluated the effect of sertraline on the plasma protein binding of warfarin. On days and 32 of the study, all participants were given warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either the sertraline or the placebo group; the sertraline dose was raised incrementally from 50 mg/day to 200 mg/day. Prothrombin time was measured before each warfarin dose and periodically afterward. The investigators concluded that sertraline did not enhance the anticoagulant effects of warfarin to a clinically significant degree, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown an association between the use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on data from published observational studies, exposure to SSRIs, especially in the month prior to delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events related to SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Sertraline and Reviparin together?
Combining sertraline with reviparin adds up to a higher bleeding risk, so keep taking both as prescribed but watch for bleeding and report any bruising or bleeding to your care team. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Reviparin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Reviparin interaction managed?
Both medicines raise bleeding risk, so the main approach is watchful monitoring, not stopping treatment. Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Your care team may monitor you more closely and individualize your blood-thinner plan. Watch for warning signs: frequent nosebleeds, easy bruising, tiny red skin spots, blood in urine or stool, black stools, or b… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Reviparin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Reviparin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist